share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4:持股變動聲明-董事 Farokhzad Omid
美股sec公告 ·  07/12 16:22
Moomoo AI 已提取核心訊息
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
2024年7月10日,Farokhzad Omid參與了涉及Senti Biosciences,Inc.(SNTI)的交易。在公告中未披露交易類型、狀態、股份數量、股份性質、交易價格及股票總值等具體細節。Farokhzad Omid與發行人的關係也未明確。沒有這些細節,這筆交易對Farokhzad Omid的持股和Senti Biosciences的影響對投資者來說仍然不清楚。
2024年7月10日,Farokhzad Omid參與了涉及Senti Biosciences,Inc.(SNTI)的交易。在公告中未披露交易類型、狀態、股份數量、股份性質、交易價格及股票總值等具體細節。Farokhzad Omid與發行人的關係也未明確。沒有這些細節,這筆交易對Farokhzad Omid的持股和Senti Biosciences的影響對投資者來說仍然不清楚。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息